Implantation of a Permanent Interatrial Shunt to Reduce Left Atrial Filling Pressures Following MitraClip
| 対象疾患 | Heart Failure, Mitral Regurgitation |
|---|---|
| 相 | 該当なし |
| スポンサー | samir kapadia |
| ステータス | 実施中（募集終了） |
| 参加者数 | 16 名 |
| 介入（薬剤） | V-Wave Shunt Placement |
| 開始日 | 2021年3月11日 |
| 完了日 | 2025年1月3日 |
| 結果公開日 | 2026年8月5日 |
概要
This is an investigator initiated, prospective study to demonstrate the safety and feasibility of implantation of the V-Wave Interatrial Shunt System (herein called the "V-Wave Shunt" in patients immediately following percutaneous mitral valve repair using the MitraClip system.
Number of Occurrence for Device-related Major Adverse Cardiovascular and Neurologic Events (MACNE)
| Treatment | 3 events |
|---|
BENITIONS で見る ClinicalTrials.gov の原文を見る
同じ疾患の他の治験
- Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant — University of Utah
- Mechanism and Effects of Manipulating Chloride Homeostasis in Acute Heart Failure — Yale University
- Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using th — Boston Children's Hospital
- PROACTIVE-HF IDE Trial Heart Failure NYHA Class III — Endotronix, Inc.
- Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coord — Weill Medical College of Cornell University
- Crome/Cobalt Respiration Study — Medtronic Cardiac Rhythm and Heart Failure